As of Mar 27
| +0.53 / +2.08%|
The 5 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 38.00 and a low estimate of 24.00. The median estimate represents a -7.83% decrease from the last price of 26.04.
The current consensus among 6 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.